ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DNDN (MM)

0.1314
0.00 (0.00%)
07 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
(MM) NASDAQ:DNDN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.1314 0 00:00:00

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

29/10/2009 11:30am

PR Newswire (US)


(MM) (NASDAQ:DNDN)
Historical Stock Chart


From Feb 2020 to Feb 2025

Click Here for more (MM) Charts.
SEATTLE, Oct. 29 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the following upcoming investor conferences. Merriman Investor Summit 2009 New York City Tuesday, November 10, 2009 11:00 a.m. ET Credit Suisse 2009 Healthcare Conference Phoenix, Arizona Friday, November 13, 2009 11:30 a.m. ET Lazard Capital Markets 6th Annual Healthcare Conference New York City Tuesday, November 17, 2009 10:55 a.m. ET The presentations will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com/. Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/. DATASOURCE: Dendreon Corporation CONTACT: Jennifer Williams, Investor Relations of Dendreon Corporation, +1-206-829-1500 Web Site: http://www.dendreon.com/

Copyright

1 Year (MM) Chart

1 Year (MM) Chart

1 Month (MM) Chart

1 Month (MM) Chart

Your Recent History

Delayed Upgrade Clock